MedTrace Logo

EVT in Acute Basilar Artery Occlusion With Large Infarction Core

NCT07090941 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 348

Last updated 2025-07-29

No results posted yet for this study

Summary

A multicenter, prospective, open-label, blinded endpoint, randomized controlled trial designed to evaluate the efficacy and safety of best medical management (BMM) combined with endovascular treatment (EVT) versus BMM alone in acute basilar artery occlusion (BAO) patients with large infarct cores.

Conditions

  • Basilar Artery Occlusion
  • Large Ischemic Core
  • Large Core Infarct
  • Endovascular Treatments

Interventions

PROCEDURE

Endovascular Treatment

The vascular access route is selected based on the patient's anatomical characteristics and operator discretion. Endovascular treatment (EVT) procedures must adhere to each participating center's standardized operating protocols. Upon confirmation of vascular occlusion, EVT may be performed using devices approved by China's National Medical Products Administration (NMPA). Based on lesion-specific features and operator judgment, permissible techniques include stent retriever thrombectomy, aspiration thrombectomy, balloon angioplasty with or without stenting, or intra-arterial thrombolysis. Investigational devices are strictly prohibited.

Sponsors & Collaborators

  • The First Affiliated Hospital of Hainan Medical University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2027-09-30
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07090941 on ClinicalTrials.gov